An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)
Clinical trial NCT02105688 · COMPLETED
Trial details
- NCT number
- NCT02105688
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-02
- Primary completion
- 2015-06-10
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.